AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported a fourth-quarter 2013 loss of 32 cents per share (excluding one-time expenses), narrower than the year-ago loss of 43 cents per share and the Zacks Consensus Estimate of a loss of 40 cents. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) stock opened at $1.79 in last session, and closed at $1.70, while the day range of stock is $1.67 – $1.80. The stock showed a negative weekly performance of -10.53%.
Zalicus Inc. (NASDAQ:ZLCS) a bio-pharmaceutical company that discovers and develops novel treatments for patients suffering from pain, reported financial results for the fourth quarter and year ended December 31, 2013. Zalicus Inc (NASDAQ:ZLCS) stock opened at $1.31, in last session and closed at $1.25, by losing -5.30%. The 52 week range of the stock is $0.88 – $8.28. Company’s market capitalization is $32.61 million.
Coronado Biosciences, Inc. (NASDAQ:CNDO) announced its financial results for the fourth quarter and year ended December 31, 2013. Coronado Biosciences Inc (NASDAQ:CNDO) stock decreased -10.67% and finished the last session at $2.26. The EPS of the stock remained -1.33. Company’s market capitalization is $76.71 million.
Shares of Omeros Corporation (NASDAQ:OMER) , a clinical-stage bio-pharmaceutical company focused on developing therapies to treat inflammation, coagulopathies, and central nervous system disorders, fell as much as 11% after announcing a share offering of common stock and reporting its fourth-quarter earnings results after the closing bell last night. Omeros Corporation (NASDAQ:OMER) stock opened the session at $11.50, and closed the session at $11.35. The 52 week range of the stock remained $3.65 – $14.69 and the day range was $11.00 – $11.59.